Understanding How Naltrexone Affects Social Experiences
This study aims to understand how the medication naltrexone affects how people experience social situations and how their brain responds. We are looking for healthy individuals aged 18 to 25. Participants will take either naltrexone or a placebo (a sugar pill) once a day for 7 days. We will measure your daily feelings of social connection and mood. On the last day, you will have an MRI scan to see how your brain reacts to social tasks. The study is currently unclear on its recruitment status and plans to enroll 210 participants. Success would mean understanding how naltrexone impacts social feelings and brain activity.
- Study design
- This is a randomized, placebo-controlled study, meaning participants will be randomly assigned to receive either naltrexone or a placebo. It plans to enroll 210 participants.
- What's involved
- You will take a pill once a day for 7 days and complete daily reports on your feelings. On day 7, you will visit a facility for an MRI scan and complete tasks.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your daily feelings will be measured across 7 days, and brain activity and feelings in response to tasks will be measured on Day 7.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences
At a glance
Conditions
NCT05007561
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
San Diego State University
San Diego, Californiano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Tristen Inagaki, PhD · PRINCIPAL_INVESTIGATOR · San Diego State University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Daily feelings of social connection via ecological momentary assessmentpost-treatment, change across 7 days
State feelings of social connection outside of the lab
- Bold Oxygen-level Dependent (BOLD) Activations in Prespecified ROIsDay 7, approximately 60 mins after taking study drug
In the MRI scanner, participants read sentences written by people they know and people they do not know in a block design. In a second task they view images of people they know, those they do not know, and other emotional images. Brain activity will be measured as BOLD activity in response to stimuli from known (vs. unknown) people using functional magnetic resonance imaging (FMRI). Based on a priori hypotheses, brain activity will be masked to activity in structural regions-of- interest (ROIs) of the ventral striatum (VS), middle-insula (MI), anterior cingulate cortex (ACC) and ventromedial prefrontal cortex (VMPFC).
- feelings in response to neuroimaging tasksDay 7, approximately 150 minutes after taking study drug
Feelings of social connection and general positive affect in response to the neuroimaging tasks will be reported on a scale of 1 (not at all) to 7 (very)